Financials Asian Phytoceuticals

Equities

APCO

TH1077A10Z09

Personal Products

End-of-day quote Thailand S.E. 06:00:00 2024-06-06 pm EDT 5-day change 1st Jan Change
7.15 THB +1.42% Intraday chart for Asian Phytoceuticals +10.85% +37.50%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,400 1,944 2,256 3,810 3,000 3,120
Enterprise Value (EV) 1 1,904 1,464 2,134 3,677 2,835 2,904
P/E ratio 25.3 x 32.4 x 32.2 x 55.5 x 37.1 x 29 x
Yield 3.87% 2.93% 3.19% 1.94% 3.1% 3.46%
Capitalization / Revenue 6.49 x 7.85 x 9.11 x 17.1 x 12 x 10.7 x
EV / Revenue 5.15 x 5.91 x 8.61 x 16.5 x 11.3 x 9.92 x
EV / EBITDA 15.4 x 18.7 x 24.4 x 45.1 x 29.9 x 23.5 x
EV / FCF 30 x 26.1 x 30.8 x 49.4 x 32.5 x 29.3 x
FCF Yield 3.33% 3.84% 3.25% 2.02% 3.08% 3.42%
Price to Book 3.91 x 3.36 x 3.79 x 6.4 x 4.93 x 5.12 x
Nbr of stocks (in thousands) 600,000 600,000 600,000 600,000 600,000 600,000
Reference price 2 4.000 3.240 3.760 6.350 5.000 5.200
Announcement Date 2/21/19 2/26/20 2/22/21 2/28/22 2/27/23 2/28/24
1THB in Million2THB
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 369.8 247.7 247.7 223.4 250.4 292.8
EBITDA 1 123.8 78.35 87.51 81.48 94.84 123.7
EBIT 1 110.1 64.89 75.53 73.82 88.03 116.9
Operating Margin 29.78% 26.2% 30.49% 33.05% 35.16% 39.93%
Earnings before Tax (EBT) 1 117.7 72.36 87.07 85.49 100.5 133.2
Net income 1 94.75 57.9 69.98 68.7 80.92 107.5
Net margin 25.62% 23.38% 28.25% 30.76% 32.32% 36.72%
EPS 2 0.1579 0.1000 0.1166 0.1145 0.1349 0.1792
Free Cash Flow 1 63.45 56.18 69.28 74.42 87.31 99.28
FCF margin 17.16% 22.68% 27.97% 33.32% 34.87% 33.91%
FCF Conversion (EBITDA) 51.27% 71.7% 79.18% 91.34% 92.06% 80.27%
FCF Conversion (Net income) 66.97% 97.02% 99.01% 108.33% 107.9% 92.36%
Dividend per Share 2 0.1549 0.0950 0.1200 0.1234 0.1550 0.1800
Announcement Date 2/21/19 2/26/20 2/22/21 2/28/22 2/27/23 2/28/24
1THB in Million2THB
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 496 480 122 133 165 216
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 63.4 56.2 69.3 74.4 87.3 99.3
ROE (net income / shareholders' equity) 15.3% 9.7% 11.9% 11.5% 13.5% 17.8%
ROA (Net income/ Total Assets) 10.2% 6.26% 7.12% 6.7% 8.09% 10.6%
Assets 1 925.2 924.8 983.1 1,025 1,001 1,019
Book Value Per Share 2 1.020 0.9700 0.9900 0.9900 1.010 1.020
Cash Flow per Share 2 0.3000 0.2700 0.1700 0.1600 0.1400 0.2100
Capex 1 3.43 1.21 4.18 1.17 0.32 3.37
Capex / Sales 0.93% 0.49% 1.69% 0.53% 0.13% 1.15%
Announcement Date 2/21/19 2/26/20 2/22/21 2/28/22 2/27/23 2/28/24
1THB in Million2THB
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. APCO Stock
  4. Financials Asian Phytoceuticals